|Assessment Status||Assessment process complete|
|Indication||Management of opiate addiction|
|Full submission received from Applicant||02/01/2014|
|NCPE assessment completed||22/05/2014|
|NCPE assessment outcome||Reimbursement Not Recommended|
Pharmacoeconomic Evaluation completed in November 2007. Suboxone cannot be considered a cost effective option for patients attending HSE clinics or in the community setting in Ireland.
Pharmacoeconomic Reassessment completed in 2014. The NCPE does not consider Suboxone® to be cost-effective compared to methadone for the treatment of opioid dependence.